Abstract: The present disclosure relates the use of a beta blocker for the manufacture of a medicament for the treatment of hemangiomas, for example of infantile hemangiomas. The beta blocker may be a non-selective beta-blocker, for example propranolol. The present disclosure provides an alternative to the known compounds, e.g. corticosteroids, interferon or vincristine, generally used for the treatment of hemangiomas.
Type:
Grant
Filed:
October 16, 2008
Date of Patent:
December 25, 2012
Assignee:
Université Victor Segalen—Bordeaux 2
Inventors:
Christine Léauté-Labrèze, Éric Dumas De La Roque, Alain Taieb, Jean-Benoît Thambo